This pack contains 10 individual vials, each with 30mg of Retatrutide (LY3437943) a tri-agonist peptide that targets GLP-1, GIP, and glucagon receptors. BulkGLP sources raw Retatrutide, verifies its identity and purity through third-party HPLC analysis, and prepares vials in-house without excipients or bulking agents.
This format is ideal for researchers conducting multiple studies or requiring repeatable, batch-consistent trials.
⚠️ Potency Advisory
This product is prepared without mannitol or excipients that may dilute or buffer the compound. Our in-house preparation preserves the concentration and activity of the raw peptide.
Researchers may observe stronger receptor activity and faster uptake compared to diluted or pre-filled formats.
Always begin with microdose-level trials. Do not assume equivalence to externally sourced materials.
Appearance Note
This is pure lyophilized Retatrutide with no added sugars, fillers, or stabilizers. Powder may appear collapsed, fragmented, or partially dispersed this is normal for clean, unbuffered peptide and does not affect quality.
What you’re seeing is real compound not filler.
Specifications
-
Product Name: Retatrutide (GLP-3 Tri-Agonist) – 10-Pack
-
Catalog Number: RET-30MG-10X
-
Quantity: 10 Vials × 30mg (Total 50mg)
-
Purity: >98.5% (Verified by Third-Party HPLC)
-
Appearance: White powder
-
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
-
Molecular Weight: ~4731.33 g/mol
-
CAS Number: 2381089-83-2
-
Preparation: No mannitol. No buffers. No fillers.
Storage
-
Lyophilized: Store at -20°C or colder
-
After reconstitution: Refrigerate at 36–46°F (2–8°C)
-
Avoid repeated freeze-thaw cycles
Research Applications
For laboratory research on GLP-1, GIP, and glucagon receptor agonism. Suitable for metabolic, signaling, and dose-ranging studies.
⚠️ Disclaimer
For research use only. Not for human or veterinary use. BulkGLP does not operate as a compounding pharmacy or 503B facility. This compound is not intended to diagnose, treat, or prevent any disease.